Researchers at Thomas Jefferson University Hospital have shown that combining distal protection devices with the prophylactic use of the drug nicardipine can reduce the risk of complications following ...
"The reasons for these findings likely represent our lack of a complete understanding of the factors involved in no-reflow/distal embolization phenomena." The use of a distal embolic protection device ...
United States Embolic Protection Device Market is expected to reach US$ 650 million by 2033 from US$ 360 million in 2024, with a CAGR of 6.96% from 2025 to 2033. Rising cardiovascular operations, ...
Myocardial perfusion after primary percutaneous coronary intervention (PCI) in the acute phase of myocardial infarction (MI) is often suboptimal despite high rates of restoration of normal coronary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results